Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Self-Injurious Behavior
- Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
- Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome
- The Effect of Intravenous Ketamine on Non Suicidal Self Injuries.
- Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome
- Propranolol for Challenging Behaviors in Autism
- Signatures of N-Ac for Non-Suicidal Self-Injury in Adolescents
- A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder
- Evaluation of Naltrexone as a Treatment for Self-injurious Behavior
- Rapalogues for Autism Phenotype in TSC: A Feasibility Study
- Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
- Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents
- Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease
- N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
- Double-Blind Lamictal (Lamotrigine) in Neurotic Excoriation
- Treatment Strategies for Children With Smith-Magenis Syndrome
- Repetitive Behavior Disorders in People With Severe Mental Retardation
- An Open-Label Study Of Lamictal In Neurotic Excoriation
- Self-Injury: Diagnosis and Treatment
- Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome